chrisvoncsefalvay/vaers-outcomes huggingface dataset:
89 yo female received J&J COVID-19 vaccination on 3/20/2021. On 3/24, pt determined to have cardioembolic stroke. CTA showed acute R M1/ICA occlusion. She went for thrombectomy where TICI2b revascularization was achieved. Patient was taking apixaban 2.5mg BID prior to admission. History of cancer and DVT, on chronic anticoagulation. LKW 3/22 (2 days after vaccine) with intermittent spells of expressive aphasia an L sided shaking. CTH neg. BL duplex with no DVT.
I experienced side effects from the COVID vaccine, including notable fatigue, chills/shaking, body aches for approximately 2 days. The third day I woke up without any symptoms.
Last night a pruritic rash began on his shoulders and back and is present today when he came for treatment.
Information has been received from a healthcare worker (operations manager) referring to unknown number of patients. On unknown dates, the patients were administered improperly stored RECOMBIVAX HB lot # J013394, expiry date: 25-AUG-2016, (route, dose and frequency were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Two hours after vaccine patient had blood pressure of 160/90 and heart rate of 170. At 6:30pm patient still had blood pressure of 170/110. Urged patient again to go to urgent care. As of the next day patient said she felt dizzy after vaccine but felt better. She did not go to urgent care. However, her right arm where she received the vaccine is difficult to move.
Per report received from hospital, Pt. was pulseless, apneic, cyanotic unresponsive upon arrival. Father doing CPR upon EMS arrival. Pt. pulseless per report. Grandmother reported child "was fine" at 1:00 AM.
Pt managed by non-PCP. States previously received the influenza vaccine outside the clinic and developed facial swelling as a result. Denies any future influenza vaccines.
She was having a sore throat. I took her to the primary care doctor for it. They put her on antibiotics. She just got done with the medicine yesterday.
Patient reported (12 days post vaccine) still experiencing mild to moderate pain in the arm of vaccination. No swelling or redness reported. No other symptoms reported.
I had a fever for 3 days of 103F. After which, I had strong abdominal pain. I had to stop and use the bathroom every 2 minutes it seems. I was bloated. I was in pain. I had blood in my urine. I have never had a UTI or a kidney problem and so I got scared and called my doctor and she said that was normal, that the vaccine causes bloating. And just like she told me, they went away as fast as they came. But my arm hurt so bad, the abdominal pain was so bad, the UTI was so severe and it took me almost 12 hours to stop feeling like I was dying, and I will not take a booster now because of this. I have had Covid before, but I beat it. I am of a healthy weight, healthy lifestyle. And I rather get Covid again then another vaccine. Inflammation is normal for vaccine but what if it was my heart? My brain? No thank you.
noticed slight swelling of throat; hives on right arm; Day of vaccination and day after headaches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 16:00 as dose 4 (booster), single (Lot number: GH9702) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious) with onset 12Oct2022 at 09:00, outcome "recovering", described as "Day of vaccination and day after headaches"; URTICARIA (non-serious) with onset 14Oct2022, outcome "recovering", described as "hives on right arm"; PHARYNGEAL SWELLING (non-serious) with onset 14Oct2022, outcome "recovering", described as "noticed slight swelling of throat". Therapeutic measures were taken as a result of headache, pharyngeal swelling, urticaria.  Additional information: The patient had no known allergies. The patient did not receive other vaccine in four weeks or other medications in two weeks. Day of vaccination and day after headaches. 14Oct noticed hives on right arm and noticed slight swelling of throat. The patient took Benadryl-antihistamine which mitigated symptoms such as itching. The patient took OTC antihistamines which helped. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Systemic trunk reaction and extremity rash; extremity rash; This spontaneous report has been received from a nurse practitioner referring to a 1-year-old female patient. Information regarding the patient's pertinent medical history, concomitant therapies and previous drug reactions or allergies was not provided. On an unknown date in 2022 (also reported as 8 days prior to having the vaccines administered), the child tested positive for COVID.  On an unknown date in 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), pneumococcal vaccine conj 13v (crm197) (PREVENAR 13), hepatitis a vaccine inact (HAVRIX), and diphtheria vaccine toxoid hepatitis b vaccine rhbsag (yeast), pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (PEDIARIX) administered for prophylaxis (also reported as 12 month shots) (strength, dose, frequency, route of administration lot number and expiration date were unknown by the reporter).  On an unknown date in 2022, the patient experienced systemic trunk reaction and extremity rash (hypersensitivity/rash). At the time of reporting, the patient was recovering from the events.  The causal relationship between the vaccines and the aforementioned events was not provided.
My upper back felt like it was on fire. Like something was activating. I felt my body fighting something. Ended up in the hospital.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Lot number: Ew0173), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Long covid" (unspecified if ongoing), notes: Other medical history: Long covid; "If covid prior vaccination: Yes" (unspecified if ongoing), notes: If covid prior vaccination: Yes; "PPD" (unspecified if ongoing), notes: Maybe samll dose of Zoloft for ppd. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Lot Number was Ew0187, Vaccine location was right arm), for COVID-19 immunization. The following information was reported: BACK PAIN (hospitalization, disability) with onset 12Jun2022, outcome "recovered with sequelae", described as "My upper back felt like it was on fire. Like something was activating. I felt my body fighting something. Ended up in the hospital.". The event "my upper back felt like it was on fire. like something was activating. i felt my body fighting something. ended up in the hospital." required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Computerised tomogram: Unknown results; Magnetic resonance imaging: Unknown results; Ultrasound scan: Unknown results, notes: they don't know what's wrong. Therapeutic measures were taken as a result of back pain.  Clinical information: My upper back felt like it was on fire. Like something was activating. Patient felt my body fighting something. Ended up in the hospital. Patient have been in and out of the hospitals, mris, cat scans, zrays, ultra sounds they don't know what's wrong.AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage.If covid prior vaccination was yes and if covid tested post vaccination was no.
Patient reported pain, swelling, itching, and bruising about 1-2 inches below injection site.
Heart palpitations, tachycardia, hypertension, nausea, lightheadedness and shortness of breath during first episode. These episodes continues for 6 months after my second injection.  Officially my vision would also start to go black. Episodes typically lasted for 1-3 hours.
AT night could not move his arm. Had to put it in position where he wanted. The shot may have been too high according to him. Sore for a couple of day.
c/o of HA, rx c ibuprofen and relief noted, On 10/31/2009 had a severe HA, generalized for three days tx with aleve/ibuprofen. 11/3/2009 c/o of continued HA, generalized malaise, some nausea
Information has been received from a consumer concerning her 17 year old daughter, who on an unspecified date, was vaccinated with a second dose of GARDASIL.  Subsequently, the patient didn't feel too well and fainted.  The patient was seen at the office.  At the time of the report, the outcome of the patient was unknown.  Additional information is not expected.
got the / vaccine and two months later shingles / on the cornea of left eye / Suspected Vaccination failure; two months later shingles / on the cornea of left eye / returned two other times; so painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster and pain were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and pain to be related to Shingles vaccine.  Additional details were provided as follows:  The patient had reported the case for himself/herself. The age at vaccination was not reported. The patient got the Shingles vaccine and two months later shingles appeared on the cornea of left eye which was so painful. The reporter mentioned that, it returned two other times and now at the time of reporting it had been gone. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible, as no contact details were available.
Went in to try and wake her up and could not so; Suddenly she felt like she had to sit down; Does not remember anything/  memory seems worse/ forget what she is saying in the middle of a sentence; 2 millimeter cyst on her ovary; Lack of energy; And then threw up; So exhausted that she has to lay down after; Had a 102 degree fever; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Went in to try and wake her up and could not so) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced PYREXIA (Had a 102 degree fever). On 25-Jun-2021, the patient experienced LOSS OF CONSCIOUSNESS (Went in to try and wake her up and could not so) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced FEELING ABNORMAL (Suddenly she felt like she had to sit down), MEMORY IMPAIRMENT (Does not remember anything/  memory seems worse/ forget what she is saying in the middle of a sentence), OVARIAN CYST (2 millimeter cyst on her ovary), ASTHENIA (Lack of energy), VOMITING (And then threw up) and FATIGUE (So exhausted that she has to lay down after). At the time of the report, LOSS OF CONSCIOUSNESS (Went in to try and wake her up and could not so), FEELING ABNORMAL (Suddenly she felt like she had to sit down), MEMORY IMPAIRMENT (Does not remember anything/  memory seems worse/ forget what she is saying in the middle of a sentence), OVARIAN CYST (2 millimeter cyst on her ovary), ASTHENIA (Lack of energy), VOMITING (And then threw up), PYREXIA (Had a 102 degree fever) and FATIGUE (So exhausted that she has to lay down after) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 102f (High) 102F.         No concomitant medications were provided by the reporter.   Treatment information was not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  More information has been requested.   This case was linked to MOD-2021-310293 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  More information has been requested.
Heaviness across the chest and harder to get deep breath when needed.  Lasted throughout the evening and night but was OK the next morning.
No adverse event; received 0.5ml of the regular Moderna COVID19 vaccine instead of the bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (received 0.5ml of the regular Moderna COVID19 vaccine instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052b22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (received 0.5ml of the regular Moderna COVID19 vaccine instead of the bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received 0.5ml of the regular Moderna COVID19 vaccine instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received 0.5ml of the regular Moderna COVID19 vaccine instead of the bivalent booster).    No concomitant information was reported. It was unknown that which dose was given to the patient. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-657007 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-657007:Case for patient patient 2
Information has been received from a physician, for pregnancy registration for GARDASIL, concerning a 17 year old female with no previous pregnancy who on 13-NOV-2009 was vaccinated with the first dose of GARDASIL (lot #: 660612/0229X). It was reported that the patient was pregnant at the time of vaccination. On an unspecified date, ultrasound was performed and it showed the patient's estimated delivery date was 05-JUL-2010 (also reported as 2009). First trimester screening and other screening were performed. The patient's last menstrual period was 28-SEP-2009. Follow-up information was received from a licensed practical nurse. It was reported that the patient's pregnancy was "without complication". However, she added that the mother was scheduled for a cesarean section on 29-JUN-2010 secondary to genital warts. The reporter confirmed it was due to genital warts during her pregnancy not due to herpes lesions. On 29-JUN-2010 the patient presented with spontaneous rupture of membranes and the cesarean was performed. The mother delivered a healthy baby, weighed 7 lbs, 1 oz. The mother recovered fully from the surgery without complication. Both mother and baby were doing well at the time of her postpartum exam. Upon internal overview, genital warts was determined to be an other important event. No further information is available.
Pain in joints of toes & left knee.  No redness, warmth, or swelling.  Right middle finger swollen and painful since 1/18/2010 and persists currently.
COVID-19 arm per personal research online. Itchy raised welt like area at injection site.
This case was received from a health professional on 24 May 2007. A 4-year-old patient received an injection of YF-Vax (lot number not reported) and subsequently developed elevated liver enzymes and "may have developed hepatitis". No additional information was provided. 6/21/07-records received for DOS 5/20-5/25/07-DC DX:Viral syndrome likely mononucleosis reactivation. Patient was in China from 3/30-4/12/07 and developed diarrhea and has not really felt well since. Admitted with fever, nausea and recurrent diarrhea. He had mono as a teenager with hepatitis.
Soreness at injection site and surrounding tissue.  Moderate to severe headache.  No treatment.  Both resolved in 36hrs after injection.
Fever, Diarrhea,  Abdominal pain, comes and goes, fatigue, chills Narrative:
shingles; This spontaneous report was received from a lawyer and refers to a currently 80 year-old patient of unknown gender concerning a case in litigation. The patient's concurrent conditions, medical history, historical drugs and concomitant medications were not reported.  In 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot number and expiration date were not reported) for long-term prevention of shingles and zoster-related conditions.  On an unknown date, the patient experienced shingles, and was treated witn unspecified medication.   The outcome of herpes zoster was unknown.     The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
About 3-4 hours after vaccine administration, patient developed several large about 5 X 6 cm confluent, pruritic erythematous papular plagues on upper forearms and lower legs.
I had shortness of breath, fatigue, headache, dizziness. I didn't feel sick, I just felt lousy. I went to the hospital; they check me for my heart. They did an EKG, two sets of blood work, and an x-ray. Everything came back normal. They sent we home with no treatment. They told me to follow up with my primary care doctor.
blood pressure was 160/100 and requires medication to control.  Also, when I received the 2nd dose, it spiked again to about the same even though I was still medicated for it daily with lisinopril. So I believe that the vaccine is what has caused my high blood pressure.
Received Menactra in our office 7/27/05, saw his allergist 7/30/05 and had to receive a breathing treatment, MD questioned if related to Menactra. 50 cent size raised warm area around injection site.
Pt collapsed at service desk of local store, nurse called to scene, found lying on floor, not moving, no apparent breathing, face pale and lips blue. Nurse immediately gave Epinephrine 1:1000 0.5 ml into left deltoid. Pt aroused, turned onto side and the paramedics arrived to stabilize pt for transport to local hospital.
pt recv vax 30NOV95 & 29APR96 pt devel 6-7 lesions under lt arm;they appeared nowhere else;MD noted that a cult of pt lesion was positive for herpes zoster;
Fever of 102.8 given 200mg of Ibuprofen By 3:10 am fever was 103.2 and she was delusional (Insisting that she was going to school attempting to dress herself over pj's) Given additional 200mg of ibuprofen, Cold cloth. By 7:00 am temp was 101.0 given additional 200mg of ibuprofen and taken to Dr.
patient experienced the event of did worse on her 6 minute walk; Increased to 11 breaths of Tyvaso; not been feeling well; This is a spontaneous report from a contactable consumer or other non hcp (patient) received via Pfizer from regulatory authority (Manufacturer Report No: UNT-2021-005040).A 81-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 15Mar2021 (Batch/Lot number was not reported)(at the age of 81-year-old)  as dose number unknown, single for COVID-19 immunization, treprostinil sodium (TYVASO, concentration of 0.6 mg/ml) delivered by Tyvaso inhalation device (TD-300/A) (device only) via an inhalation route of administration from 04Jan2021 (Batch/Lot number was not reported) to an unspecified date, at unspecified dose, via inhalation route of administration from an unspecified date (Batch/Lot Number: 2101910; Expiration Date: 31Oct2021) to an unspecified date, at 18-54 microgram, four times a day and via inhalation route of administration from 15Mar2021 (Batch/Lot number was not reported) to an unspecified date, at 66 microgram for pulmonary arterial hypertension. Medical history included ongoing pulmonary arterial hypertension. Concomitant medications included sildenafil citrate and diltiazem hydrochloride. On 15Mar2021, patient experienced increased to 11 breaths of tyvaso and not been feeling well. On 18Mar2021, patient experienced the event of did worse on her 6-minute walk. It was reported that on 15Mar2021, 2 months 12 days after initiating IH Tyvaso the patient had not been feeling well and the patient got her Covid-19 vaccine and she increased to 66 microgram (11 breaths) of IH Tyvaso (off label use) on the same day. On 18Mar2021 (Yesterday), 2 months 15 days after initiating IH Tyvaso, the patient did worse on her 6-minute walk test at physician visit. The patient underwent lab tests and procedures which included walking distance test: worse on her 6-minute walk on 18Mar2021. The action taken in response to the events for treprostinil sodium was unknown. The outcome of the events was unknown.  The reporter's causality for the event malaise with IH Tyvaso was considered to be possibly related. The reporter did not provide causality for the event of walking distance test.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Left thigh with localized rxn, redness with induration directly under vaccination, mild warmth. Pt had temp day after vaccine reported as 105 degmether, nonfocal exam except as above.  Treated with Tylenol and local ice.